Semi-Annual Statement Of Cash Flows

Medix Inc. - Filing #7248202

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
951,856,000 JPY
787,703,000 JPY
Depreciation
45,369,000 JPY
41,252,000 JPY
Increase (decrease) in allowance for doubtful accounts
-714,000 JPY
359,000 JPY
Interest and dividend income
-2,684,000 JPY
-925,000 JPY
Interest expenses
2,418,000 JPY
3,736,000 JPY
Increase (decrease) in provision for retirement benefits
40,819,000 JPY
36,179,000 JPY
Increase (decrease) in provision for bonuses
-25,073,000 JPY
-41,017,000 JPY
Decrease (increase) in trade receivables
66,417,000 JPY
-50,709,000 JPY
Other, net
91,916,000 JPY
-51,344,000 JPY
Subtotal
875,626,000 JPY
727,684,000 JPY
Interest and dividends received
2,418,000 JPY
656,000 JPY
Interest paid
-2,362,000 JPY
-3,736,000 JPY
Income taxes paid
-375,987,000 JPY
-48,768,000 JPY
Net cash provided by (used in) operating activities
499,948,000 JPY
675,834,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-14,188,000 JPY
-35,122,000 JPY
Proceeds from collection of loans receivable
5,018,000 JPY
11,293,000 JPY
Net cash provided by (used in) investing activities
414,355,000 JPY
8,507,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
100,000,000 JPY
Repayments of long-term borrowings
-229,000,000 JPY
-256,000,000 JPY
Proceeds from issuance of shares
368,000,000 JPY
JPY
Purchase of treasury shares
JPY
-16,239,000 JPY
Dividends paid
-60,240,000 JPY
-45,480,000 JPY
Net cash provided by (used in) financing activities
76,286,000 JPY
-217,719,000 JPY
Net increase (decrease) in cash and cash equivalents
990,591,000 JPY
466,623,000 JPY
Cash and cash equivalents
3,771,068,000 JPY
2,780,477,000 JPY
2,313,853,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.